A key advantage of NKT cells over conventional T cells may be their remarkable intrinsic anti-tumor activity, which is activated by glycolipids presented by CD1d on antigen-presenting cells through their endogenous T cell receptors (TCRs) (28, 29). The gene discussed is CD1D; the disease is neoplasm.